Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jeremias Wohlschläger"'
Autor:
Hamza Aljabali, Jakob Heidborn, Turkan Hajili, Kristina Greimelmaier, Jeremias Wohlschläger, Stephan Kruck, Gerd Reis, Tillmann Loch
Publikováno v:
Journal of Urology. 207
Autor:
Hideo A. Baba, Jeremias Wohlschläger, Elke Lainka, Ali Canbay, Julia Kälsch, Suzan Schwertheim, Sarah Theurer
Publikováno v:
Der Pathologe. 41:505-514
Die Lebertransplantation ist eine etablierte Therapieoption zur Behandlung von Patienten mit einer irreversiblen Lebererkrankung im Endstadium. Das Therapiemanagement der Patienten erfolgt interdisziplinar und verlangt von den Pathologen Kenntnisse s
Autor:
Thomas Hager, Dirk Theegarten, Jeremias Wohlschläger, Matthias Heldwein, Marcel Treml, Lars Hagmeyer, Simon Herkenrath, Winfried Randerath, Khosro Hekmat
Publikováno v:
Thorax. 74(7)
Sixty-one subjects with fibrosing interstitial lung disease were prospectively analysed to determine the efficacy of transbronchial cryobiopsy (CryoTBB) and the effect of procedural modifications which were introduced after an interim analysis of the
Autor:
Dirk Theegarten, Winfried Randerath, Sandhya Matthes, Christina Priegnitz, Marcel Treml, Lars Hagmeyer, Jeremias Wohlschläger
Publikováno v:
The Clinical Respiratory Journal. 10:589-595
Background and Aims It is not yet known if transbronchial cryobiopsy (TCB) is a reliable and safe diagnostic tool in the investigation of interstitial lung disease (ILD). To date, there have been no studies directly comparing the value of TCB with th
Autor:
Ulrich H. Frey, Ursula Rauen, Jörg F. Schlaak, Jeremias Wohlschläger, Christoph E. Broelsch, Christian D. Fingas, Ali Canbay, Shin-Yi Sheu, Maximilian Bockhorn, Georgios C. Sotiropoulos
Publikováno v:
Transplantation. 86:1578-1585
BACKGROUND Inadequate liver regeneration is still an unsolved problem in major liver resection and living donor liver transplantation (LDLT). Therefore, we have investigated the use of erythropoietin (EPO) as an exogenous stimulator of liver regenera
Autor:
Anne-Margret Wingen, Rainer Büscher, Udo Vester, Klaus-Eugen Bonzel, Anja K. Arbeiter, Jens Nürnberger, Peter F. Hoyer, Carsten Bergmann, Jeremias Wohlschläger, Klaus Zerres
Publikováno v:
Nephrology Dialysis Transplantation. 23:3026-3029
Autor:
Lars, Hagmeyer, Dirk, Theegarten, Jeremias, Wohlschläger, Marcel, Treml, Sandhya, Matthes, Christina, Priegnitz, Winfried J, Randerath
Publikováno v:
The clinical respiratory journal. 10(5)
It is not yet known if transbronchial cryobiopsy (TCB) is a reliable and safe diagnostic tool in the investigation of interstitial lung disease (ILD). To date, there have been no studies directly comparing the value of TCB with that of surgical lung
Autor:
Ali Canbay, Hideo A. Baba, Carolin Pütter, Dominik A. Megger, Henning Reis, Barbara Sitek, Helmut E. Meyer, Jeremias Wohlschläger, Jörg F. Schlaak, AC Hoffmann, Frank Weber, André Scherag, Martin Eisenacher, Sascha Hagemann, Stefanie Bertram, Thilo Bracht
Publikováno v:
Biochimica et biophysica acta. 1854(6)
Hepatocellular carcinoma (HCC) is a major lethal cancer worldwide. Despite sophisticated diagnostic algorithms, the differential diagnosis of small liver nodules still is difficult. While imaging techniques have advanced, adjuvant protein-biomarkers
Autor:
Thomas Minor, Anja Gallinat, Ursula Rauen, Jeremias Wohlschläger, Dieter P. Hoyer, Sandra Swoboda, Andreas Paul
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 27(10)
Summary Machine perfusion for preservation led to compelling success for the outcome of renal transplantation. Further refinements of methods to decrease preservation injury remain an issue of high interest. This study investigates functional and mor
Autor:
Jeremias Wohlschläger, Ali Canbay, Anna-Carinna Suttorp, Martin Schlattjan, Lars P. Bechmann, Sascha Hagemann, Patricia Wenzel, Kerstin Herzer, Henning Reis, Hideo A. Baba
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 35(3)
Background & Aims Orthotopic liver transplantation (OLT) is the sole therapeutic option to cure end-stage liver diseases including HCV-related cirrhosis. Timely and precise differentiation of relevant acute HCV reinfection from acute rejection after